1-(3-Chlorobenzyl)-3-(5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-one

Catalog No. :
ACLGYB756
CAS No. :
477852-94-1
Molecular Formula :
C21H14Cl3N3O2S
Molecular Weight :
478.79

IUPAC Name:1-(3-chlorobenzyl)-3-(5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-one

1-(3-Chlorobenzyl)-3-(5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chlorobenzyl)-3-(5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-one
IUPAC Name1-(3-chlorobenzyl)-3-(5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-one
Molecular FormulaC21H14Cl3N3O2S
Molecular Weight478.79
SMILESO=C1C(C2=NN=C(SCC3=CC=C(Cl)C=C3Cl)O2)=CC=CN1CC4=CC=CC(Cl)=C4
InChI KeyZGVTZCRJRBWSCP-UHFFFAOYSA-N
Synonym1-(3-CHLOROBENZYL)-3-(5-[(2,4-DICHLOROBENZYL)SULFANYL]-1,3,4-OXADIAZOL-2-YL)-2(1H)-PYRIDINONE;1-[(3-chlorophenyl)methyl]-3-(5-{[(2,4-dichlorophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)-1,2-dihydropyridin-2-one;2(1H)-Pyridinone, 1-[(3-chlorophenyl)methyl]-3-[5-[[(2,4-dichlorophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-
CAS No.477852-94-1

Synthetic Route by SureRoute

1. ACLGYB756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWGM620 route compound structure diagram
    ACOWGM62020443-99-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGYB756 route product structure diagram
    ACLGYB756477852-94-1
Inquiry

2. ACLGYB756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGYB756 route product structure diagram
    ACLGYB756477852-94-1
Inquiry

Comments (0)